Archive

EU renews mandate of drug watchdog chief

Written by Gary Finnegan | 20 May 2025

The European Medicines Agency (EMA) looks set to extend the contract of its Executive Director, Emer Cooke. The Agency’s Management Board unanimously recommended renewing her mandate at a… read more.

Over 1.2 million medical device side-effect reports not submitted within legal timeframe

Written by Charlie King | 18 Mar 2025

Over 1.2 million medical device adverse event reports were not submitted to the US Food and Drug Administration (FDA) within the deadline set by federal regulations, finds an… read more.

EU drug watchdog warns of scams using regulator’s logo

Written by Gary Finnegan | 8 Mar 2025

The European Medicines Agency (EMA), the EU’s drug regulator, is warning the public and companies to beware of fraud. The agency has been alerted to several scams and… read more.

EU drug regulators agree common approach to data transparency

Written by Gary Finnegan | 27 Dec 2024

The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have published a comprehensive overhaul of their guidance on the identification of commercially confidential information (CCI) and… read more.

Revising Medicare Part D prescription drug policy could save billions

Written by Charlie King | 16 Oct 2024

Removing protected class regulation from Medicare prescription drug policies could greatly reduce the United States’ prescription drug spending—this could have saved potentially $47 billion between 2011-2019, according to… read more.